PATENT CLAIM ANALYSIS

Application Number: 15969864
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-09
Patent Classification: ["544", "281000"]

Abstract:
The invention is fused heterocyclic compounds of formula (I), and salts thereof, compositions thereof, and methods of use therefor. In particular, disclosed herein are certain fused heterocyclic compounds that can be useful for inhibiting protein kinase, including Bruton's tyrosine kinase (Btk), and for treating disorders mediated thereby.

Claim (Index 9):
The compound of  claim 5  wherein R 4  is 1-acryloylpiperidin-4-yl (compound 27) or 1-(but-2-ynoyl) piperidin-4-yl (compound 176).

Metadata:
- Claim Count in Document: 46.0
- Percentile: 93.0
- Lexical Diversity: 1.39535
- Patent Class: 544.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['14951494', '14723417', '15359871', '14349144', '11399484']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8230175476792458
- 35 USC 102 Novelty (BERT): 0.5666058692546769
- Combined Prediction Score: 0.797376379836789
- Mean Citation Score: 461.024532
- Max Citation Score: 532.4433
- Similarity Product: 315.40888220431214

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test